The Latest Breaking News on Pharma

Pliant Therapeutics unveiled promising results for a lung disease treatment on Monday, and PLRX stock rocketed into the stratosphere.

Teva said Monday it plans to knock off Catalyst's only approved drug and CPRX stock — which has sat atop the IBD 50 for weeks — crashed.

Captagon is a synthetic drug that has turned Syria into a narco-state. The illicit industry behind this amphetamine is estimated to be worth billions of dollars, with over 400 million tablets seized in the Middle East in 2021. So who is profiting from this trafficking? Where is the drug produced?…

The party is launching a plan it says will help fix the pressures on the health service.

Yale and Harvard researchers found the drugs with big ad spends aren't generally the best drugs. Here's why

MIAMI — A group of scientists say they’ve created a safer version of fentanyl that could potentially diminish the drug’s addictive side effects, which have resulted in annual deaths of tens of thousands of people across the United States.

Juul Labs Inc. won preliminary approval of a settlement aimed at resolving thousands of lawsuits targeting the e-cigarette maker as a major cause of a US youth-vaping epidemic.

Shkreli received lifetime ban from industry over monopoly pricing on life-saving Daraprim drug

Eli Lilly stock dipped Friday after the FDA unexpectedly rejected its request for an accelerated approval of its Alzheimer's treatment.

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.